SBI Pharmaceuticals Co., Ltd. – Trademark Portfolio
Entity Type: 03
SBI Pharmaceuticals Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ALADUCK.
6-1, Roppongi 1-chome,
Minato-ku Tokyo 106-6020
Showing of trademarks Trademarks
Trademark Classifications
SBI Pharmaceuticals Co., Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does SBI Pharmaceuticals Co., Ltd. have?
SBI Pharmaceuticals Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered.
What trademark classes does SBI Pharmaceuticals Co., Ltd. file in?
SBI Pharmaceuticals Co., Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are SBI Pharmaceuticals Co., Ltd.'s most well-known trademarks?
SBI Pharmaceuticals Co., Ltd.'s registered trademark portfolio includes well-known marks such as ALADUCK. These are among 1 currently registered trademark in the portfolio.
What is SBI Pharmaceuticals Co., Ltd.'s trademark registration success rate?
SBI Pharmaceuticals Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.